Therapeutic Potential of Stem Cells Strategy for Cardiovascular Diseases
Open Access
- 1 January 2016
- journal article
- review article
- Published by Wiley in Stem Cells International
- Vol. 2016 (1) , 4285938
Abstract
Despite development of medicine, cardiovascular diseases (CVDs) are still the leading cause of mortality and morbidity worldwide. Over the past 10 years, various stem cells have been utilized in therapeutic strategies for the treatment of CVDs. CVDs are characterized by a broad range of pathological reactions including inflammation, necrosis, hyperplasia, and hypertrophy. However, the causes of CVDs are still unclear. While there is a limit to the currently available target‐dependent treatments, the therapeutic potential of stem cells is very attractive for the treatment of CVDs because of their paracrine effects, anti‐inflammatory activity, and immunomodulatory capacity. Various studies have recently reported increased therapeutic potential of transplantation of microRNA‐ (miRNA‐) overexpressing stem cells or small‐molecule‐treated cells. In addition to treatment with drugs or overexpressed miRNA in stem cells, stem cell‐derived extracellular vesicles also have therapeutic potential because they can deliver the stem cell‐specific RNA and protein into the host cell, thereby improving cell viability. Here, we reported the state of stem cell‐based therapy for the treatment of CVDs and the potential for cell‐free based therapy.Keywords
Funding Information
- Pusan National University
This publication has 111 references indexed in Scilit:
- Heart repair by reprogramming non-myocytes with cardiac transcription factorsNature, 2012
- Mice generated from tetraploid complementation competent iPS cells show similar developmental features as those from ES cells but are prone to tumorigenesisCell Research, 2011
- Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cellsNature Communications, 2011
- Genomic instability in induced stem cellsCell Death & Differentiation, 2011
- Concise Review: Mesenchymal Stem Cell Treatment of the Complications of Diabetes MellitusStem Cells, 2011
- Direct Reprogramming of Fibroblasts into Functional Cardiomyocytes by Defined FactorsCell, 2010
- MicroRNA Regulation of Cell Lineages in Mouse and Human Embryonic Stem CellsCell Stem Cell, 2008
- Pre-Treatment of Mesenchymal Stem Cells With a Combination of Growth Factors Enhances Gap Junction Formation, Cytoprotective Effect on Cardiomyocytes, and Therapeutic Efficacy for Myocardial InfarctionJACC, 2008
- Generation of germline-competent induced pluripotent stem cellsNature, 2007
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006